...
首页> 外文期刊>Developments in biological standardization >Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.
【24h】

Development of a nitric oxide induction assay as a potential replacement for the intracerebral mouse protection test for potency assay of pertussis whole cell vaccines.

机译:一氧化氮诱导测定法的发展,可能替代百日咳全细胞疫苗效价测定的脑内小鼠保护试验。

获取原文
获取原文并翻译 | 示例
           

摘要

The intracerebral mouse protection test (Kendrick test) for the potency assay of pertussis vaccines is a complex and time consuming in vivo test which has a significant intra- and interlaboratory variation. Thus, there is a pressing need to develop a replacement for the Kendrick test. There is now convincing evidence to suggest that Bordetella pertussis can be taken up and survive within macrophages in the lungs and that cell-mediated immunity plays a role in protection. It was hypothesised that murine macrophages could be activated by immunisation with whole cell pertussis vaccines and therefore induce NO production. An alternative in vitro assay based on the determination of reactive nitrogen intermediates produced as a result of macrophage activation has been examined as a possible replacement for the current intracerebral (i.c.) mouse protection test. NO induction was studied in the peritoneal macrophages of female NIH mice immunised with normal and denatured whole cell B. pertussis vaccines respectively. Compared with controls receiving diluent only, macrophages and spleen cells from mice immunised with whole cell pertussis vaccine responded in vitro to selected pertussis antigens by NO synthesis. The production of NO in response to in vitro culture with bacterial antigen was immunisation dose dependent and was correlated with protective immunity in vivo as determined by i.c. challenge. The results suggest that NO production may serve as a marker of macrophage activation in mice immunised with whole cell vaccine, and could form the basis of a potential replacement potency assay.
机译:用于百日咳疫苗效价测定的脑内小鼠保护试验(Kendrick试验)是一项复杂而耗时的体内试验,在实验室内和实验室间存在显着差异。因此,迫切需要开发一种替代Kendrick检验的方法。现在有令人信服的证据表明,百日咳博德特氏菌可以在肺中的巨噬细胞中摄取和存活,并且细胞介导的免疫在保护中起作用。假设通过全细胞百日咳疫苗免疫可以激活鼠巨噬细胞,从而诱导NO的产生。已经研究了基于确定由于巨噬细胞活化而产生的反应性氮中间产物的另一种体外测定法,它可以替代当前的脑内(i.c.)小鼠保护试验。在分别用正常和变性全细胞百日咳博德特氏菌疫苗免疫的雌性NIH小鼠的腹膜巨噬细胞中研究了NO诱导。与仅接受稀释剂的对照组相比,用全细胞百日咳疫苗免疫的小鼠的巨噬细胞和脾细胞在体外通过NO合成对选定的百日咳抗原产生反应。响应于用细菌抗原的体外培养产生的NO的产生是免疫剂量依赖性的,并且与通过i.c.测定的体内保护性免疫有关。挑战。结果表明,NO的产生可能是用全细胞疫苗免疫的小鼠中巨噬细胞活化的标志,并可能构成潜在的替代效力测定的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号